1.1Lower milk protein concentration
Dilute the milk retentate with water to 3% protein by weight. Hydrate a small dose of low-acyl gellan gum in a separate hot water phase and blend it into the milk base to provide light body.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
Dilute the milk retentate with water to 3% protein by weight. Hydrate a small dose of low-acyl gellan gum in a separate hot water phase and blend it into the milk base to provide light body.
Feed low-mineral water into the circulating retentate at the same rate that permeate leaves the membrane. Soluble calcium and small dissolved salts pass into the permeate while the membrane retains milk proteins.
Pass a portion of the skim milk through a fixed bed of sodium-form cation-exchange resin. The resin takes up dissolved calcium and releases sodium, and the treated stream is blended with untreated skim milk to set the calcium level before ultrafiltration.
Use fresh skim milk retentate as the base for a plain dairy beverage. Apply a short thermal hold and cool the beverage promptly to limit the development of cooked flavors.
Dissolve low-gel-strength gelatin in the warm milk base so it forms a weak network on refrigeration and softens as the beverage warms toward 30 °C. Adjust the gelatin concentration using apparent viscosity measurements at 2 and 30 °C taken at the same shear rate after a defined conditioning period.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A peach-flavored ultrafiltered milk beverage contains 6% milk protein by weight and 8 mM tripotassium citrate. A chilled reservoir feeds a portioning pump that delivers fixed volumes to meal trays. Before loading a batch, a technician measures viscosity at a fixed shear rate across 2 to 30 °C and verifies that the highest and lowest readings differ by less than 150 cP.
Tripotassium citrate replaces sodium polyphosphate as the calcium-binding ingredient in an ultrafiltered milk beverage containing 7% milk protein by weight and a strawberry flavorant. The citrate dissolves in the dilution water before that water enters the milk concentrate, and the blended beverage undergoes homogenization followed by heat treatment. A bench series spans 4 to 16 mM citrate, and the finished formulation uses the lowest tested dose that keeps the viscosity difference below 150 cP across 2 to 30 °C at a fixed shear rate.
A pilot line blends 30 kg/h of ultrafiltered milk concentrate containing 14% milk protein by weight with 40 kg/h of water containing coffee flavorant and dissolved tripotassium citrate. The combined stream contains 6% milk protein by weight, and the citrate feed targets 10 mM in the combined stream. An inline mixer feeds a homogenizer and a continuous heat exchanger set to 137 °C with a four-second holding section, followed by rapid cooling. A temperature sweep at a fixed shear rate checks the finished beverage against a viscosity difference below 150 cP from 2 to 30 °C.
An ultrafiltered milk blend containing 7% milk protein by weight, 10 mM tripotassium citrate, and a banana flavorant feeds a homogenizer and a tubular heat exchanger. A holding tube provides the specified thermal residence time, and a downstream cooler delivers the beverage to an aseptic surge tank. The tank supplies an aseptic carton filler under sterile air pressure. Samples from sealed cartons undergo a fixed-shear temperature sweep from 2 to 30 °C to verify a viscosity difference below 150 cP.
A programmable controller meters citrate solution into an ultrafiltered milk blend containing 7% milk protein by weight and raspberry flavorant. After heat treatment and cooling, an automated sampler sends an aliquot to a temperature-controlled rotational viscometer that performs a stepped sweep from 2 to 30 °C at a fixed shear rate. The controller calculates the difference between the highest and lowest readings and releases a batch when the difference is below 150 cP. If a batch exceeds the limit, the controller holds it for review and selects a higher citrate dose for the next batch from a calibration table bounded at 1 and 30 mM.
A calibrated inline near-infrared sensor estimates milk protein concentration in the ultrafiltered concentrate, and mass flowmeters measure the concentrate and dilution streams. A controller adjusts the dilution-water pump to reach 7% milk protein by weight and meters a separate tripotassium citrate solution and pear flavorant in proportion to finished blend flow. The blend passes through a static mixer before homogenization and heat treatment. Finished samples undergo a viscosity sweep at a fixed shear rate from 2 to 30 °C to verify that the difference stays below 150 cP.
Blend milk retentate containing 16% protein by weight with the other beverage ingredients so that retentate accounts for half of the finished batch by mass. Use measured retentate protein content to adjust the batch proportions and reach 8% milk protein by weight.
Dissolve trisodium citrate in the formulation water before combining it with the milk concentrate. Set the added citrate concentration to 8 mM in the finished beverage so citrate binds a portion of the dissolved calcium.
Dissolve vanillin in a portion of the warm formulation water and mix the solution into the milk base before homogenization. Set the vanillin dose to 50 mg per kg of finished beverage.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
A preferred embodiment provides the product has at least 10% up to 25% milk protein.B · US 9,907,330 B2 · ¶ 9
The “calcium sequestration agent” or “calcium binding agent” of the present invention is any agent capable of binding or sequestering calcium ion (CaII) such that the bound or sequestered calcium ion is prevented or inhibited (i.e., reduced) from interacting with other binding agents.A · US 2016/0030321 A1 · ¶ 45
Flavor and distribution of fat in the matrix of the chip was improved when buttermilk was added.B · US 9,907,330 B2 · ¶ 68
The composition obtained as described in Example 1 was then filled into an airless pump container (e.g., 30 ml TopFill airless pump from MegaPlast—Mega Pumps) and then tested for physical stability (color, odor, viscosity, pH, appearance, etc.) under accelerated conditions (40 to 50° C.) for up to three months.A · US 2016/0030321 A1 · ¶ 120
An empty cell means only that no passage was reproduced there.
However, melanogenesis and skin pigmentation can be disturbed or disorder, which may lead to undesirable pigmentation patterns.A · US 2016/0030321 A1 · ¶ 13
This has lead to research to find compounds that will inhibit melanogenesis and reduce skin pigmentation.A · US 2016/0030321 A1 · ¶ 13
One example is with products consumed by athletes building muscle mass, or where a person suffers from lean body mass loss due to illness or excessive physical activity.B · US 9,907,330 B2 · ¶ 2
Consuming protein can enhance muscle mass and strength.B · US 9,907,330 B2 · ¶ 2
patent.fyi, US 2026/0354423 A1, claim 1, first published 2026-11-18T22:28:45-05:00, https://patent.fyi/US20260354423/, SHA-256 633f63af3497161f9131ff4a414bd71cc80d7e9960994d4463883fd3802a68f8